Rethink praises Ontario's decision to provide breast cancer patients with Herceptin

[News]

Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.

More... (http://www.news-medical.net/news/20110513/Rethink-praises-Ontarios-decision-to-provide-breast-cancer-patients-with-Herceptin.aspx)